How much funding has Sutro Biopharma raised?

Sutro Biopharma has raised $168.9M in total funding, most recently a Series E round.

Who are Sutro Biopharma's investors?

Sutro Biopharma's investors include SV Health Investors, Samsara BioCapital, Surveyor Capital, Alta Partners, Skyline Global Partners, Eli Lilly.

When was Sutro Biopharma founded?

Sutro Biopharma was founded in 2003.

Where is Sutro Biopharma headquartered?

Sutro Biopharma is headquartered in South San Francisco, California, United States.

What industry is Sutro Biopharma in?

Sutro Biopharma operates in Biotech, Healthcare.

How many employees does Sutro Biopharma have?

Sutro Biopharma has 201-500 employees.

Sutro Biopharma

IPO

Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.

Public · South San Francisco, United States · Founded 2003 · $168.9M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 201–500
Founded: 2003
Business Model: B2B
Website: sutrobio.com

Total Funding: $168.9M
Last Round: $85.4M Series EJul 2018
Rounds: 5
Type: Public

About

Sutro Biopharma is a clinical-stage oncology company pioneering site-specific and novel-format ADCs using its proprietary cell-free protein synthesis platform.

Summary

Sutro Biopharma is a Biotech company based in South San Francisco, United States, founded in 2003. It has raised $168.9M in total across 5 rounds, most recently a $85.4M Series E round in Jul 2018. Investors include SV Health Investors, Samsara BioCapital and Surveyor Capital.

LinkedIn X (Twitter)